Tag: thursday
-
Otonomy’s ear infection drug succeeds in late-stage trial
(Reuters) – Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection in the outer ear canal, met the main goal in a late-stage trial. AOE, also known as swimmer’s ear, is a type of bacterial infection causing inflammation in the external ear canal. Children suffering from middle-ear…
-
Duck cull in France’s foie gras region to contain bird flu
French authorities have started slaughtering ducks in the main foie gras-producing region to try to contain a dangerous form of bird flu. Operations to destroy birds got underway Thursday in three departments …
-
Duck cull in France’s foie gras region to contain bird flu
French authorities have started slaughtering ducks in the main foie gras-producing region to try to contain a dangerous form of bird flu. Operations to destroy birds got underway Thursday in three departments …
-
Halozyme’s pancreatic cancer drug succeeds in mid-stage trial
(Reuters) – Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and Eli Lilly and Co succeeded in a mid-stage study involving patients with an advanced form of pancreatic cancer. Shares of Halozyme were up 47.3 percent at $15.77 in trading before the opening bell on Thursday. Halozyme’s…
-
Halozyme’s pancreatic cancer drug succeeds in mid-stage trial
(Reuters) – Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and Eli Lilly and Co succeeded in a mid-stage study involving patients with an advanced form of pancreatic cancer. Shares of Halozyme were up 47.3 percent at $15.77 in trading before the opening bell on Thursday. Halozyme’s…
-
Synthetic Biologics’ C. difficile mid-stage study meets main goal
(Reuters) – Synthetic Biologics Inc said on Thursday its experimental product designed to reduce antibiotic-resistant infections outperformed a placebo in a mid-stage trial. The company’s oral enzyme ribaxamase met the main goal of significantly reducing Clostridium difficile infection (CDI) versus a placebo in the 412-patient study. Prolonged use of antibiotics can allow this common intestinal…
-
Trump moves to quickly fill his top Cabinet ranks
By Emily Stephenson NEW YORK (Reuters) – U.S. President-elect Donald Trump said he expected to have most members of his Cabinet announced next week, interviewing more candidates at Trump Tower for top jobs in his administration as he prepares to take office on Jan. 20. Trump is still weighing who to choose as secretary of…
-
New data on risk vs benefit for potent CAR-T cancer drugs
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. Experimental chimeric antigen receptor T-cells, or CAR-Ts, are made by genetically altering a patients’ own…
-
U.S. pushes to close lead testing gaps, echoing Reuters report
By Joshua Schneyer and M.B. Pell NEW YORK (Reuters) – U.S. states must do more to ensure that all children enrolled in the Medicaid health care program are tested for lead poisoning, a U.S. Government agency said this week, acknowledging major gaps in screening that were highlighted in a recent Reuters investigation. In a bulletin…
-
Wal-Mart to settle U.S. lawsuit over benefits for same-sex spouses
Wal-Mart and lawyers for Jacqueline Cote, the worker who filed the 2015 lawsuit in federal court in Boston, said in a court filing that the money may be split among more than 1,000 people who were denied spousal benefits between 2011 and 2014, when Wal-Mart changed its policy. Sally Welborn, a senior vice president at…